17 November 2014
A new production line has opened in Moscow’s Strogino Technopark to synthesize innovation drugs, the website of Moscow’s TVTs TV channel reported.
According to the website, the new Russian drugs are “superior in a range of parameters to German analogs” and are manufactured nowhere else in Russia.
The drugs reportedly help improve cerebral blood circulation and prevent depressions. They are effective in preventing strokes, too, the source said.
The new drugs are administered to the mucous membranes of a patient’s nasal cavity and are said to be able to quickly spread across organs and tissues, reaching a damaged area in the brain and preventing the death of cells.
Starting with a capacity of 600,000 vials a year, the new site is expected to boost production sevenfold “very soon” to as many as four million.
16 May 2024
NovaMedica team participates in the Russian Pharmaceutical Forum in St. Petersburg
14 May 2024
27 April 2024
The Moscow Department of Clinical Research processed 78 applications for drug trials over two years
21 May 2024
Cell therapy could help curb progression of heart failure
20 May 2024
China may find various medicines from the Gamaleya Center interesting
20 May 2024
The number of conducted clinical trials in Russia is growing
17 May 2024